# "Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.

> **NCT05888701** · — · UNKNOWN · sponsor: **University of Milano Bicocca** · enrollment: 30 (estimated)

## Conditions studied

- Mantle-cell Lymphoma
- B Cell Chronic Lymphocytic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05888701
- **Lead sponsor:** University of Milano Bicocca
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-08
- **Primary completion:** 2023-09
- **Final completion:** 2024-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05888701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05888701, ""Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05888701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*